Beauty Health (NASDAQ:SKIN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, Zacks.com reports. The firm presently has a $21.00 price objective on the stock. Zacks Investment Research‘s price objective would suggest a potential upside of 37.80% from the company’s previous close.
According to Zacks, “The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. “
SKIN has been the subject of a number of other reports. William Blair assumed coverage on Beauty Health in a research note on Friday, January 7th. They issued an “outperform” rating for the company. DA Davidson upped their price target on Beauty Health from $26.00 to $32.00 and gave the company a “buy” rating in a research note on Wednesday, November 10th. Stifel Nicolaus assumed coverage on Beauty Health in a research note on Thursday, October 7th. They issued a “buy” rating and a $33.00 price target for the company. Cowen assumed coverage on Beauty Health in a research note on Monday, October 4th. They issued an “outperform” rating and a $32.00 price target for the company. Finally, Raymond James assumed coverage on Beauty Health in a research note on Thursday, December 23rd. They issued a “market perform” rating for the company. One investment analyst has rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, Beauty Health presently has an average rating of “Buy” and a consensus target price of $28.22.
Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Monday, November 8th. The company reported ($1.63) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.03) by ($1.60). The company had revenue of $68.15 million during the quarter, compared to analyst estimates of $59.57 million. On average, sell-side analysts forecast that Beauty Health will post -0.09 EPS for the current year.
A number of large investors have recently added to or reduced their stakes in SKIN. Rhumbline Advisers acquired a new position in Beauty Health during the 2nd quarter worth approximately $758,000. Sei Investments Co. acquired a new position in Beauty Health during the 2nd quarter worth approximately $2,342,000. Ameritas Investment Partners Inc. acquired a new position in Beauty Health during the 2nd quarter worth approximately $61,000. Rockefeller Capital Management L.P. acquired a new position in Beauty Health during the 2nd quarter worth approximately $1,276,000. Finally, Citigroup Inc. acquired a new position in Beauty Health during the 2nd quarter worth approximately $826,000. 62.08% of the stock is owned by hedge funds and other institutional investors.
About Beauty Health
Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems.
Recommended Story: 52-week highs
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.